Crossmark

Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Crossref DOI link: https://doi.org/10.1016/j.jacc.2020.03.064

Published Print: 2020-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Ho, Carolyn Y.

Mealiffe, Matthew E.

Bach, Richard G.

Bhattacharya, Mondira

Choudhury, Lubna

Edelberg, Jay M.

Hegde, Sheila M.

Jacoby, Daniel

Lakdawala, Neal K.

Lester, Steven J.

Ma, Yanfei

Marian, Ali J.

Nagueh, Sherif F.

Owens, Anjali

Rader, Florian

Saberi, Sara

Sehnert, Amy J.

Sherrid, Mark V.

Solomon, Scott D.

Wang, Andrew

Wever-Pinzon, Omar

Wong, Timothy C.

Heitner, Stephen B.
License Information

Text and Data Mining valid from 2020-06-01

Text and Data Mining valid from 2020-06-01

Version of Record valid from 2020-04-07
More Information

This article is maintained by: Elsevier

Article Title: Evaluation of Mavacamten in Symptomatic Patients With Nonobstructive Hypertrophic Cardiomyopathy

Journal Title: Journal of the American College of Cardiology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacc.2020.03.064

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.